The role of improved pre-transfusion testing in the prevention of delayed serologic transfusion reactions among blood recipients in Uganda: a Randomized Controlled Trial (IPAT Study)
![Thumbnail](/xmlui/bitstream/handle/123456789/1049/The%20role%20of%20improved%20pre-transfusion%20testing%20in%20the%20prevention%20of%20delayed%20serologic%20transfusion%20reactions%20among%20blood%20recipients%20in%20Uganda.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Date
2019Author
Natukunda, Bernard
Ndeezi, Grace
Er, Lay See
Bajunirwe, Francis
Teramura, Gayle
Delaney, Meghan
Metadata
Show full item recordAbstract
Background and objectives: The goal of pre-transfusion testing (PTT) is to provide patients with beneficial and safe transfusions. In Uganda, PTT includes ABO/RhD typing plus room temperature (RT) saline cross-matches without red-blood-cell (RBC) alloantibody screening. The aim of the IPAT study was to assess the role of improved PTT in the prevention of delayed serologic transfusion reactions (DSTRs).
Materials and methods: In this randomized controlled trial, patients at Mbarara Hospital in Uganda, with a history of RBC exposure, were randomized 1:1 to have either RBC alloantibody screening (SCREEN group) or room temperature saline cross-matches (CONTROL group) during PTT. ‘Home-made’ reagent RBCs from group O RhD-positive volunteers were used for antibody screening in the indirect antiglobulin test. Participants were evaluated for RBC alloantibody production 7– 14 days after transfusion. Post-transfusion haemoglobin estimation and direct
antiglobulin tests (DATs) were also performed.
Results: We randomized 220 patients to either the SCREEN or CONTROL group. Both study arms had similar demographic and transfusion characteristics at baseline. There were 19 (17_3%) individuals in the CONTROL group with DSTRs compared to 8 (7_3%) in the SCREEN group at the time of follow-up (P = 0_02). Overall, post-transfusion DATs were positive in 7 (3_5%) patients but there was no associated decrease in haemoglobin levels.
Conclusion: Red-blood-cell alloantibody screening is associated with occurrence of significantly fewer DSTRs. The use of ‘home-made’ reagent cells during PTT in Uganda is feasible. We recommend a change in the local PTT policy to consider the introduction of RBC alloantibody screening.
Collections
- Research Articles [432]
Related items
Showing items related by title, author, creator and subject.
-
Red blood cell alloimmunization in transfused patients in sub-Saharan Africa: A systematic review and meta-analysis
Ngoma, Alain M.; Mutombo, Paulin B.; Ikeda, Kazuhiko; Nollet, Kenneth E.; Natukunda, Bernard; Ohto, Hitoshi (Transfusion and Apheresis Science, 2016)Background and objectives: Previous studies of Sub-Saharan Africans show significant alloimmunization to red blood cell (RBC) antigens, but country-specific data are limited. Thus, the aim of this study was to estimate, ... -
Assessment of the clinical transfusion practice at a regional referral hospital in Uganda
Natukunda, B.; Schonewille, H.; Sibinga, C. Th. Smit (Transfusion medicine, 2010)The aim of this study was to determine the indications for transfusion, blood ordering practices and post-transfusion complications, and to assess the clinical transfusion practice at Mbarara Regional Referral Hospital ... -
The utility of ‘home-made’ reagent red blood cells for antibody screening during pre-transfusion compatibility testing in Uganda
Natukunda, Bernard; Wagub, Robert; Taremwa, Ivan; Okongo, Benson; Mbalibulha, Yona; Teramura, Gayle; Delaney, Meghan (African Health Sciences, 2021)Background: The WHO recommends that pre-transfusion testing should include ABO/RhD grouping followed by screening for red blood cell (RBC) alloantibodies using the indirect antiglobulin test (IAT). However, in Uganda, ...